These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 23148799

  • 1. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH, Tepper SJ, Wein T, Schweizer E, Ramos E.
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group.
    J Int Med Res; 1994 Jan; 22(4):225-35. PubMed ID: 7958382
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991 Jan; 31(5):323-31. PubMed ID: 1653140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K, Tfelt-Hansen P, Hansen EW, Krøis EH, Pedersen OS.
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
    Gross ML, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H.
    Headache; 1994 Oct; 34(10):559-63. PubMed ID: 7843948
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP, Pierce M, O'Neill C, Foster S, Jennings C.
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
    Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D.
    Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.
    McDonald SA, Hershey AD, Pearlman E, Lewis D, Winner PK, Rothner D, Linder SL, Runken MC, Richard NE, Derosier FJ.
    Headache; 2011 Oct; 51(9):1374-87. PubMed ID: 21797863
    [Abstract] [Full Text] [Related]

  • 19. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study.
    Fujita M, Sato K, Nishioka H, Sakai F.
    Cephalalgia; 2014 Apr; 34(5):365-75. PubMed ID: 24163282
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.